Testing Status of AZT + Methadone HCl (AIDS) M920012
CASRN: AZTMETHCOMB
Related: AIDS INITIATIVE
Synonyms/Common Names
- 3'-Azido-3'-deoxythymidine + Methadone Hydrochloride
Secondary:
- 30516-87-1 - 3'-Azido-3'-deoxythymidine (AIDS)
- 30516-87-1 - AZT transplacental carcinogenesis study
- 1095-90-5 - Methadone hydrochloride
Short-Term Toxicity
- 13 weeks (Gavage)
(C92014)
Completed
- Mice: B6C3F1
- Dose: AZT: 200, 400, OR 800 MG/KG/DAY WITH METHADONE HCL: 5, 15, OR 30 MG/KG/DAY.
Special Studies
- Toxicokinetic Study (Gavage; Intravenous; Gavage; Intravenous)
(S0305)
Completed
- Female Mice: B6C3F1; Male Mice: B6C3F1; Female Mice: B6C3F1; Female Mice: Swiss CD-1
- Dose: IV: AZT: 100 MG/KG METHADONE: 0 MG/KG & AZT: 0 MG/KG METHADONE: 2.5 ORAL: AZT: 100 METHADONE: 0 AZT: 200 METHADONE: 0 AZT: 400 METHADONE: 0 OR 15 AND AZT: 0 METHADONE: 2.5 AZT: 0 METHADONE: 7.5 AZT: 0 OR 400 METHADONE: 15 MG/KG chemtasks chem00207 & 208.
Organ Systems Toxicity
- Repro/Dev Gen Tox (28-Day) (Gavage)
(RACB92023)
Completed
- Male and Female Mice: Swiss
- Dose: AZT:0, 200, 400, 800 MG/KG/DAY; METHADONE: 0, 5, 15, 30 MG/KG/DAY.